Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: EO771, the first luminal B mammary cancer cell line from C57BL/6 mice

Fig. 2

Anti-estrogenic treatments reduce EO771 cell viability. MCF-7, MDA-MB-231 and EO771 cells were treated with increasing tamoxifen (a, e and i), 4-OH-tamoxifen (b, f and j), endoxifen (c, g and k) and fulvestrant (d, h and l) concentrations for 48 h (ad), 72 h (E–H) and 96 h (il). Cell viability was measured by fluorescence using resazurin solution. The untreated condition corresponds to a viability of 100%

Back to article page